- Home
- Advocacy
- Latest News and Practice Data
- The CAP and Scientific Societies Urge Congress to Increase Funding for AMD Program
The CAP and close to 40 scientific societies, professional associations, academic institutions, and companies are urging Congress to increase funding to $175 million for the Advanced Molecular Detection (AMD) program at the Centers for Disease Control and Prevention (CDC), given its increasing importance to our nation’s public health response to infectious disease threats. In a November 3 letter[T(1] , the groups asked the House and Senate to negotiate the fiscal year 2024 Labor, Health and Human Services (HHS), Education and Related Agencies spending bill to provide the highest funding level possible. AMD integrates the latest genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation to help find, track, and stop disease-causing pathogens. AMD is also helping to ensure that the nation’s public health microbiologists, epidemiologists and other health care professionals have the tools needed to apply biotechnology-driven innovations to complex problems. This enables higher quality data and analytics that CDC and public health partners can use to detect outbreaks sooner, respond more effectively, and ensure that these tools are available in laboratories across the United States. Link to "Stakeholder CDC AMD" PDF [T(1]
The CAP and close to 40 scientific societies, professional associations, academic institutions, and companies are urging Congress to increase funding to $175 million for the Advanced Molecular Detection (AMD) program at the Centers for Disease Control and Prevention (CDC), given its increasing importance to our nation’s public health response to infectious disease threats. In a November 3 letter, the groups asked the House and Senate to negotiate the fiscal year 2024 Labor, Health and Human Services (HHS), Education and Related Agencies
spending bill to provide the highest funding level possible.
AMD integrates the latest genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation to help find, track, and stop disease-causing pathogens. AMD is also helping to ensure that the nation’s public health microbiologists, epidemiologists and other health care professionals have the tools needed to apply biotechnology-driven innovations to complex problems. This enables higher quality data and analytics that CDC and public health partners can use to detect outbreaks sooner, respond more effectively, and ensure that these tools are available in laboratories across the United States.